cancer neoantigens

NEC Becomes the First Japanese Company to Join the TESLA Consortium’s Fight Against Cancer

New Delhi, May 13, 2019: NEC Corporation (TSE: 6701) has become the first Japanese company to join the Tumor neoantigEn…

5 years ago